Clinical trials
Phase 3 Headache trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
89 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 3 |
| 2002 | 2 |
| 2003 | 7 |
| 2004 | 3 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 5 |
| 2011 | 5 |
| 2012 | 6 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 7 |
| 2016 | 3 |
| 2017 | 5 |
| 2018 | 5 |
| 2019 | 8 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 3 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 58 |
| Terminated | 9 |
| Withdrawn | 7 |
| Unknown status | 6 |
| Active, not recruiting | 3 |
| Not yet recruiting | 3 |
| Recruiting | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 10 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 7 |
| Ache Laboratorios Farmaceuticos S.A. | 4 |
| Amgen | 4 |
| Novartis Pharmaceuticals | 4 |
| Pfizer | 4 |
| University of Turin, Italy | 3 |
| Winston Laboratories | 3 |
| Bayer | 2 |
| BioCryst Pharmaceuticals | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Headache | 89 |
| Migraine Disorders | 54 |
| Pain | 7 |
| Cough | 5 |
| Influenza, Human | 5 |
| Tension-Type Headache | 5 |
| Bronchiolitis Obliterans Syndrome | 4 |
| Cluster Headache | 4 |
| Epilepsy | 4 |
| Fever | 4 |
Trials
Showing 26 to 50 of 89. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.